Background {#Sec1}
==========

Ambulatory Care Sensitive Conditions (ACSCs) are health conditions-diagnoses for which timely and effective outpatient care can help to reduce the risks of hospitalization by either preventing the onset of an illness or condition, controlling an acute episodic illness or condition, or managing a chronic disease \[[@CR1]\].

One of the first uses of ACSCs to evaluate a healthcare systems' performance was described by Billings et al. \[[@CR1]\] in 1993. Its objective was to evaluate the access to healthcare of New York's indigent population. The theory behind this is as follows: if a certain condition-diagnose can be avoided or controlled, then the need for hospitalization could also be avoided. If the actions to avoid it can be taken in the ambulatory setting, then lack of access or effectiveness of ambulatory care should result in more hospitalizations.

This means that measuring ACSC hospitalizations can indirectly indicate how well the ambulatory care setting is performing. However, this information alone is not enough to accurately identify causes of poor performance. At least two largely different dimensions need to be taken into consideration. Firstly, individuals need to have access to ambulatory care in order to have certain conditions-diagnoses addressed. Secondly, the ambulatory setting needs to be effective.

When using ACSC hospitalizations as a performance indicator, lower number/rates of hospitalizations generally mean that ambulatory care is performing well. If numbers are higher it indicates that there could be a problem in access, effectiveness or both. This is the simplistic approach. The utility and information provided by ACSC as an indicator depends on further characteristics of the context in which they are measured. Nedel et al. \[[@CR2]\] proposed major categories of influencing factors: Geographical characteristics; Sociodemographic characteristics and Model of care. The first category includes variables such as hospital proximity \[[@CR3]\] or lower populational density and isolation \[[@CR4]\], which increases the number of ACSC hospitalizations. Sociodemographic characteristics such as higher age, lower education, lower income or higher unemployment are also associated with higher rates of ACSC hospitalizations \[[@CR4]--[@CR8]\]. Comorbidities are an important risk factor \[[@CR9]\], increasing the risk of hospitalization with each chronic condition or body system affected. Finally, the model of care has a significant impact on this indicator. Not only the organization and availability of healthcare providers has an impact, with lower rates where there is higher availability \[[@CR4], [@CR10]\], but also intrinsic characteristics of the model of care such as continuity of care plays important roles. Menec et al. \[[@CR11]\] described that patients with more than 75% of consultations by the same family physician have fewer ACSC hospitalizations. Access to hospital beds also influences this indicator. If there is severe shortage of hospital beds then, even if the ambulatory care setting is not performing well, there will not be an increase in ACSC hospitalizations. On the other hand, if there is an excess of hospital beds, even if the ambulatory care setting is performing well, there might be an incentive to admit certain conditions and therefore increase ACSC hospitalizations \[[@CR2]\].

ACSC hospitalizations are only measurable after they have occurred. However, when they occur the window of opportunity to avoid them in ambulatory care has already elapsed. Therefore, this means that measuring ACSC hospitalizations depends on the availability of hospital discharge data with enough detail. The key information is the most responsible diagnosis of each hospitalization, which if included in an ACSC list flags the hospitalization as potentially avoidable. Further information is also relevant to eventually detail other relevant determinants of hospitalization, such as patients' age \[[@CR3]\] and number of comorbidities \[[@CR9]\].

Which conditions are sensitive to ambulatory care varies according to the scope of health care services and the context in which the indicator is used \[[@CR2], [@CR12]\]. Consequently, different methods to identify such hospitalizations have been developed worldwide. Different ACSCs lists have been developed since Billings et al. \[[@CR1]\] in 1993, such as Caminal et al. \[[@CR3]\], Brown et al. \[[@CR13]\], Canadian Institute for Health Information (CIHI) \[[@CR14]\], Page et al. \[[@CR15]\], Purdy et al. \[[@CR12]\], Alfradique et al. \[[@CR16]\], Freund et al. \[[@CR17]\], Sundmacher et al. \[[@CR18]\] and the United States Agency for Healthcare Research and Quality (AHRQ) \[[@CR19]\].

The process of defining ACSC lists usually starts with a literature review seeking to identify conditions with a potential relation to ambulatory care, followed by processes of discussion and validation with experts. This method aims to reach a consensus on which conditions are sensitive to ambulatory care according to the organization of care, disease mechanisms and prevalence, socioeconomic and cultural characteristics of the population and the patient course within the health system \[[@CR2], [@CR12]\].

Additionally, the inclusion of conditions usually follows specific criteria, being the Solberg and Weissman the most commonly used \[[@CR20], [@CR21]\]. These criteria include: (i) the existence of previous studies, (ii) clarity in the definition and coding of diagnoses, (iii) relevance for public health (a hospitalization rate of least 1/10,000 population), (iv) if the diagnosis is potentially avoidable by timely and effective ambulatory care and (v) the necessity of hospitalization.

The lists of ACSC developed in different countries are used by national and international institutions as a proxy for health care quality assessment. The WHO Regional Office for Europe produced a working document summarizing the evidence for using ACSC as an indicator for health care performance in the dimensions of access, quality, coordination and efficiency \[[@CR22]\]. The OECD included hospitalizations for ACSC in the list of indicators for health care performance, under the argument that high hospitalization rates indicate possibilities of improving quality and reaching substantial cost savings, given that better primary care is provided \[[@CR23], [@CR24]\]. The NHS in England has been reporting information on ACSC as part of the NHS Outcomes Framework to monitor quality of care based on conditions sensitive to its primary health care \[[@CR25]\] and has associated incentives to improve performance for certain ACSCs \[[@CR26]\]. The AHRQ developed quality indicators for health care consisting of hospitalizations for ACSC \[[@CR19]\], with conditions selected based on discussion of evidence in the dimensions of face validity, precision, minimum bias, construct validity, if it fosters true quality improvement and prior uses \[[@CR27]\]. The ACSC list developed in Brazil is available for primary health care evaluation purposes \[[@CR28]\]. In Portugal ACSS uses the rate of ACSC hospitalizations as an indicator of healthcare quality in vertical integrated healthcare units since 2016, and the ministry of health included this indicator, in a wider framework of evaluation, of primary care in 2017 \[[@CR29]\].

The need for a country-specific validated list for Portugal has already been identified \[[@CR30]\], however such tool has not been developed yet. Previous studies in Portugal have used different lists of ACSCs \[[@CR31]--[@CR34]\]. Some studies have indicated that, according to the list developed by Caminal et al. \[[@CR3]\] for Spain, rates of ACSC hospitalizations have increased during the last years in Portugal \[[@CR34]--[@CR36]\]. However, according to the CIHI list \[[@CR14]\], the rates have declined \[[@CR32], [@CR36]\]. The reason for such difference is in the methodology applied: while the Spanish list includes acute and chronic conditions, the CIHI list only contains chronic conditions. There is variation on rates of hospitalizations for ACSCs according to which conditions are selected and analysed \[[@CR12], [@CR30], [@CR37], [@CR38]\].

It was estimated that ACSCs represented 12.3% of all hospitalizations registered in mainland Portugal in 2013 \[[@CR35]\]. These hospitalizations were concentrated in five main conditions: pneumonia, congestive obstructive pulmonary disease (COPD), heart failure, hypertensive heart diseases and kidney and urinary tract infections. Around 7.3% of the hospitalizations for ACSCs were of repeated patients \[[@CR39]\].

Despite the complex framework of ACSCs determinants \[[@CR2], [@CR3]\], this is a valuable tool for health care assessment; it has been increasingly discussed not only at the academic level but also adopted by national health systems and international organizations as an indicator of performance \[[@CR14], [@CR19], [@CR22], [@CR40], [@CR41]\].

The objective of this study was to develop a list of Ambulatory Care Sensitive Conditions for Portugal. A secondary goal was to identify ACSC hospitalizations based on the developed list.

Methods {#Sec2}
=======

A modified Delphi panel approach was designed \[[@CR1], [@CR3], [@CR16], [@CR18]\], in order to determine which conditions can be considered ACSCs in the Portuguese adult population. It was web-based and asynchronous, being the answers submitted by each expert via a web-based form during a specified period of time. The experts were selected according to the following criteria: Specialist in General and Family Medicine (GP) or Internal Medicine (IM);Clinically active in the National Health Service;Preferably with an active academic collaboration;

We designed the mix of experts to be 75% GP and 25% IM. Being clinically active in the NHS was considered essential to assure the experts' knowledge of the regularly available resources. The preferable active academic collaboration was included to increase the experts' ability to understand the objectives and methods of this panel. The experts were selected, according to the defined criteria, by the most important scientific societies of each specialty, namely the Portuguese Association of General and Family Medicine (APMGF) and the Portuguese Society of Internal Medicine (SPMI). A total of 84 experts were invited to participate through an email invitation letter which included a description of the panels' objective and methods. After agreeing to participate each expert was sent a link to a web-based form (institutional SurveyMonkey® account). The panel lasted from September 2017 to May 2018.

Firstly, a brief conceptual framework of ACSC and the difference between avoidable and adequate hospitalization was delivered. The first question then was "*In your opinion, and given the current legis artis, would you consider possible to avoid the need for hospital admission in Portugal in the following clinical conditions?*". Experts were presented with a list of all previously identified ACSCs, for which a *yes/no/don't know* box was available to be ticked as well as a commentary box, should the experts wish to discuss their answer. This list of conditions was compiled in a preparatory stage by searching *Pubmed* with the keywords "Ambulatory Care Sensitive Conditions", "Avoidable admissions", and "Avoidable hospitalizations". The relevant results of this search are described in Table [1](#Tab1){ref-type="table"}. Table 1Summary of relevant papers identified during the literature review to catalogue previously defined ACSCsAuthor / InstitutionCountryYearNumber ACSCMethodWeissman, Gatsonis e Epstein \[[@CR21]\]USA199212Literature review + expert panel evaluationBillings et al. / United Hospital Fund of New York \[[@CR1]\]USA199328Modified Delphi panel (6 physicians)Sanderson e Dixon \[[@CR42]\]UK200030Modified Delphi panel (3 physician panels)Davies et al. / Agency for Healthcare Research and Quality \[[@CR27]\]USA200116 Prevention Quality Indicators (PQI)Set of measures to identify ACSC. Based on literature review, empirical testing and consensus among expert panels.Caminal et al. / Universidade Autónoma de Barcelona \[[@CR3]\]Spain200135Delphi Panel (44 experts)Brown et al. / University of Oxford \[[@CR13]\]Canada200127Delphi panel (13 experts) + Modified Delphi panel (12 experts) + questionnaire panel (11 experts)Purdy et al. / Bristol University \[[@CR12]\]UK200919Literature review.Alfradique et al. \[[@CR16]\]Brazil200920Literature review + Experts consultationWalker et al. \[[@CR43]\]Canada200918Administrative data + Expert consensus (9 experts)Freund et al. \[[@CR17]\]Germany201326AHRQ + expert selectionEggli et al. \[[@CR44]\]Switzerland201419Based on Purdy et al. + update of ICD-10 codes for specific conditionsNaumann, Augustin e Sundmacher \[[@CR45]\]Germany201432Based on Purdy et al. + 2 potentially relevant diagnosesSundmacher et al. \[[@CR18]\]Germany201522Literature review + Delphi panel (40 experts)

The second question was "*In your opinion, and given the current legis artis, would you consider possible to avoid the need for hospital admission in Portugal in any other clinical condition not previously mentioned?*". Experts had an open answer box to fill. In each round, there was a final commentary box available for questions not directly related to specific conditions.

The consensus level was defined as 75% after a maximum of three rounds \[[@CR3], [@CR18]\]. The percentual level of consensus was calculated by dividing the frequency of answers by the number of respondents in each round, multiplied by 100. To allow for the items marginally over the consensus limit to still be discussed in the following rounds the clinical conditions with a level of consensus lower than 85% were included in the following rounds. After the first and second rounds, each expert was sent an individual spreadsheet with the aggregate results of the entire panel as well as his/her answers for each clinical condition. In the second and third rounds, each non-consensual condition was accompanied by a summary of the experts' comments on the previous round. These summaries were convened after discussion between two researchers (JS and RS) and were anonymised. The clinical conditions not present in previous lists were identified by experts in the first round and still submitted to three rounds of discussion before the end of the panel.

After the experts validated the list, we identified hospitalizations for ACSC in Portugal in 2017, for the population aged 18 years or older, according to the principal diagnosis. We used the hospitalizations database provided by the Portuguese Central Administration of the Health System \[*Administração Central do Sistema de Saúde- ACSS*\]. We compiled two lists. The core list is composed by the conditions that fulfilled the criteria ii to iv proposed by Solberg and Weissman \[[@CR20], [@CR21]\]. Also an extended list is presented including all conditions agreed by the experts, despite not fulfilling all Solberg and Weissman criteria.

Costs of hospitalizations for ACSC were used to estimated potential healthcare savings associated to these events, according to the list obtained. Official hospitalization prices were used as proxy for costs, as done in previous studies in other countries \[[@CR38], [@CR46]--[@CR48]\]. These prices are defined by Diagnosis Related Groups (all patients refined diagnosis related groups version 31.0) and severity of the condition, according to values published by the Ministry of Health \[[@CR49]\].

Results {#Sec3}
=======

Of the 55 invited GPs, 28 accepted to participate (50.9%) and 25 completed all rounds (89.3%). Regarding the Internal Medicine physicians, 29 were invited, 5 accepted to participate (17.2%) and 4 completed all rounds (80%).

Table [2](#Tab2){ref-type="table"} shows the panel's results. In the first round, there was consensus (over 85%) in 22 of the 45 items (48.9%). In the second round, 7 further items achieved consensus. Finally, after three rounds, consensus (over 75%) was achieved for 34 items, leaving 11 non-consensual items (22.2%). Table 2Delphi Panel Results, pre-existing ACSCsCondition1st round2nd round3rd roundAcute myocardial infarction22,86%20,00%48,28%**Acute otitis media97,14%Acute pharyngitis97,14%Acute poliomyelitis**62,86%**86,67%Acute sinusitis91,43%Acute skin infections88,57%Acute tonsillitis97,14%**Appendicitis with complications^a^20,00%10,00%**Asthma88,57%Atrial fibrillation**71,43%76,67%**82,76%Chronic obstructive pulmonary disease / chronic bronchitis88,57%Dehydration / Hydroelectrolytic changes**80,00%83,33%**86,21%Dementia**62,86%70,00%**75,86%Dental and oral cavity pathology91,43%Diabetes mellitus (acute and chronic complications)85,71%Diphtheria**71,43%**93,33%**Epilepsy and seizures57,14%53,33%48,28%**Folate deficiency anemia91,43%**Gangrene25,71%43,33%72,41%**Gastroenteritis91,43%Heart failure**82,86%**90,00%HBV acute infection**77,14%**90,00%HBV chronic infection85,71%Hypertensive disease97,14%Infectious parotitis**82,86%**86,67%Influenza88,57%Iron deficiency anemia91,43%**Ischemic myocardial disease65,71%70,00%65,52%**Measles**82,86%**86,67%**Meningitis by *H. influenzae*48,57%63,33%48,28%Nutritional deficiencies82,86%73,33%68,97%Pelvic inflammatory disease65,71%66,67%55,17%Perforated / bleeding digestive ulcer37,14%40,00%65,52%Periamygdaline abscess60,00%56,67%51,72%**Pneumonia88,57%**Rheumatic fever65,71%76,67%68,97%**Rubella88,57%Syphilis97,14%Tetanus**68,57%**86,67%Tuberculosis**77,14%83,33%**89,66%Upper respiratory tract infection97,14%Urinary tract infections88,57%Urinary tract infections in pregnancy85,71%Vitamin B12 deficiency anemia91,43%Whooping cough**80,00%83,33%**79,31%**

Table [3](#Tab3){ref-type="table"} shows the potentially new ACSCs suggested by the experts. Out of fourteen new conditions, four achieved consensus (over 75%) after three rounds and were included as ACSCs. Table 3Delphi Panel Results, newly proposed conditionsCondition1st round2nd round3rd roundAbortion complications46,67%55,17%34,48%Alcoholic liver disease70,00%82,76%72,41%Bipolar disorder70,00%62,07%58,62%**Colorectal cancer**50,00%68,97%**75,86%**Hepatitis C73,33%82,76%68,97%HIV infection76,67%75,86%68,97%Lung cancer50,00%68,97%62,07%Melanoma60,00%65,52%55,17%Occupational accidents56,67%48,28%48,28%Occupational diseases63,33%58,62%62,07%Schizophrenia66,67%58,62%55,17%**Thromboembolic venous disease**^a^56,67%62,07%**82,76%Uterine cervical cancer**56,67%75,86%**75,86%Voluntary termination of pregnancy**80,00%79,31%**86,21%**^a^excluding pulmonary thromboembolism

Table [4](#Tab4){ref-type="table"} shows the number of hospitalizations for ACSCs in Portugal in 2017, for population aged 18 years or older, the hospitalization rate per 10,000 people and the ICD10 codes used for this identification. The conditions that fulfill the criteria ii to iv by Solberg and Weissman are in bold, and those compose the core list. In 2017, there were 847,609 hospitalizations of people aged 18 years or older; out of these, 133,427 were for ACSC (15.7% of all hospitalizations). This represents a rate of 1685 hospitalization per 100,000 adults. The most frequent diagnosis were pneumonia, heart failure, chronic obstructive pulmonary disease/chronic bronchitis, urinary tract infection, colorectal cancer, hypertensive disease atrial fibrillation and complications of diabetes mellitus. Table 4Portuguese ACSCs list, Core (in bold) and extended, ICD 10 codes and frequency of diagnosis, Portugal 2017ConditionICD 10N of ACSHsHospitalization rate (per 10,000 population)Acute otitis media^a^H65.0, H65.1, H66.02080.26Acute pharyngitis^a^J02280.03Acute poliomyelitis^a^A8010.00Acute sinusitis^a^J011110.13**Acute skin infectionsL01-L04, L0841585.25**Acute tonsillitis^a^J033660.46**AsthmaJ45, J4615131.91Atrial fibrillationI4862187.85Chronic obstructive pulmonary disease / chronic bronchitisJ40-J44, J4710,47613.23Colorectal cancer**^**b**^**C18-C20, C21.8966412.29Dehydration / Hydroelectrolytic changesE86, E87.621692.73DementiaF01, F03, G30, G31.0, G31.816672.11Dental and oral cavity pathologyA69.1, K02-K06, K08, K09, K12-K1415661.98DepressionF32, F3330633.87Diabetes mellitus (complications)E10.0, E10.1, E10.5, E10.6, E10.8, E10.9, E11.0, E11.1, E11.5, E11.6, E11.8, E11.9, E12.0, E12.1, E12.5, E12.6, E12.8, E12.9, E13.0, E13.1, E13.5, E13.6, E13.8, E13.9, E14.0, E14.1, E14.5, E14.6, E14.8, E14.9, E1554096.83**Diphtheria^a^A3600.00Folate deficiency anemia^a^D52350.04**GastroenteritisA00 - A0924123.05Heart failureI11.0, I13.0, I13.2, I50, J8123,86232.66**HBV acute infection^a^B16220.03HBV chronic infection^a^B18.0, B18.1580.07**Hypertensive diseaseI10, I11.9, I12, I13.1, I13.9, I15, I60, I61, I64, I67.467338.50**Infectious parotitis^a^B26410.05**InfluenzaJ9, J10, J118421.06Iron deficiency anemiaD5015882.00**Measles^a^B0540.00**ObesityE6626353.33PneumoniaJ13, J14, J15.3, J15.4, J15.7, J15.8, J15.9, J16.0 J16.8, J1837,20446.98**Rubella^a^B0610.00Syphilis^a^A51 -- A531120.14Tetanus^a^A33 - A3510.00Thromboembolic venous disease^a,b^I80, I82.2, I82.3, I82.8, I82.92310.29Tuberculosis^a^A15-A177780.98Upper respiratory tract infection^a^J062540.32**Uterine cervical cancer**^**b**^**C539291.17Urinary tract infectionsN10-N12, N30.0, N30.8, N30.910,34713.07**Urinary tract infections in pregnancy^a^O23.0, O23.1, O23.2, O23.3, O23.4, O23.95990.76Vitamin B12 deficiency anemia^a^D511090.13**Voluntary termination of pregnancy**^**b**^**Z3329721.23**Whooping cough^a^A3720.00^a^ Do not fulfill criteria iii^b^ Suggested by experts

Table [5](#Tab5){ref-type="table"} shows the estimated costs of hospitalizations for ACSC according to the core list. It was estimated that, in 2017, hospitalizations for ACSC in Portugal had a total cost of 352 million euros, indicating substantial healthcare costs might have been avoided. Around 48% of the total costs were for pneumonia and heart failure, and these two conditions were the most frequent. Hypertensive disease and colorectal cancer corresponded to 22% of the total costs: the average costs of each hospitalization for these conditions are the highest among all conditions (5533 and 4067 euros per hospitalization, respectively), given the complexity of these diseases. Table 5Costs of hospitalizations for ACSCConditionCost (in euros)% TotalAverage cost per hospitalization (in euros)Acute Skin Infections7,235,5842.061740Asthma2,253,4530.641489Atrial fibrillation10,968,4133.121764Chronic obstructive pulmonary disease / chronic bronchitis23,196,0976.602214Colorectal cancer39,303,60511.184067Dehydration / Hydroelectrolytic Changes3,798,3081.081751Dementia4,248,0411.212548Dental and oral cavity pathology2,362,1210.671508Depression4,874,6471.391591Diabetes mellitus (complications)12,961,7183.692396Gastroenteritis4,283,7921.221776Heart failure72,133,69720.513023Hypertensive disease37,251,49510.595533Influenza2,188,9470.622600Iron deficiency anemia2,335,4460.661470Obesity5,428,6461.542060Pneumonia97,477,55927.722620Urinary Tract Infections17,016,4414.841645Uterine cervical cancer1,726,8600.491858Voluntary termination of pregnancy624,2790.18642**Total351,669,1481002597**

Table [6](#Tab6){ref-type="table"} compares the list obtained by this study with some of the lists previously developed and in current use in other countries. It is important to mention that this table contains the broader identification of diagnostics, but specific ICD codes may vary between lists. Table 6Comparison of Portuguese list with previous listsConditionsPortugalAlfradiqueAHRQBillingsCaminalCIHIFreundPagePurdySundmacherAcute otitis mediaXXXXXAcute pharyngitisXXXXXAcute poliomyelitisXXXXXAcute sinusitisXXAcute skin infectionsXXXXXXXAcute tonsillitisXXXXXAnginaXXXXXXXAsthmaXXXXXXXXXAtrial fibrillationXX**Uterine cervical cancer**XChronic obstructive pulmonary disease / chronic bronchitisXXXXXXXX**Colorectal cancer**XDehydration / Hydroelectrolytic ChangesXXXXXXXXDementiaXXDental and oral cavity pathologyXXXXXXDepressionXXDiabetes mellitus (acute and chronic complications)XXXXXXXXXDiphtheriaXXXXXEpilepsyXXXXXXFolate deficiency anemiaXGangreneXXXXGastroenteritisXXXXXHeart failureXXXXXXXXXXHVB acute infectionXXXXXHVB chronic infectionXXXXHypertensionXXXXXXXXXInfectious ParotitisXXXXInfluenzaXXXXXIron deficiency anemiaXXXXXXXMeaslesXXXXXObesityXXPelvic inflammationXXXXXXXPerforated/bleeding ulcerXXXXXXPneumoniaXXXXXXXXRubellaXXXXXSyphilisXXXTetanusXXXXXXX**Thromboembolic venous disease**XTuberculosisXXXXXUpper respiratory tract infectionXXXXXUrinary Tract InfectionsXXXXXXUrinary tract infections in pregnancyXXVitamin B12 deficiency anemiaX**Voluntary termination of pregnancy**XWhooping coughXXXXX

Discussion {#Sec4}
==========

This section will start with the methods' discussion followed by the results' discussion. To finalize we will briefly discuss this paper's contribution to science and healthcare, as well as important underlying questions about using ACSCs as an indicator.

Regarding methods we have developed the list for the Portuguese context using the Delphi Panel method. All lists of ACSC have been developed using experts opinion to some extent, being the Delphi panel method the most frequently used \[[@CR3], [@CR16], [@CR18]\]. The reason for this is the necessary evaluation of comprehensive and complex disease mechanisms and diagnostic/treatment pathways in order to determine if a condition can be avoided and/or treated in the ambulatory setting. No other method is described. The experts' selection process is extremely important for the panels' conclusions. Therefore, we intentionally mixed GPs with IMs since their perspectives are complementary. While the first are responsible for most ambulatory care in Portugal, therefore understanding the resources available in the ambulatory setting, the latter are the most responsible for hospital admission decisions and have the end-of-the-line perspective on the pathways that lead to an ACSC hospitalization. To ensure the experts quality we defined clear selection criteria and arranged for a peer-selection by the most relevant Portuguese scientific societies in each specialty. The difference in the invitation acceptance rate between GPs (50.9%) and IMs (17.2%) is very likely related to the higher familiarity with the concept of ACSC by GPs, once these are used as a performance indicator of primary care by local, regional and national authorities. The final mix of 86% GPs was higher than initially designed. However, the IMs were fairly active during the several rounds and positively contaminated the discussion on several items.

In terms of results the experts proposed fourteen new ACSCs having four conditions achieved consensus, namely uterine cervical cancer, colorectal cancer, thromboembolic venous disease and voluntary termination of pregnancy. For both type of cancers, the experts referred to the screening undertaken in primary care as the technology that might avoid the necessity of hospitalization. The reasoning is that early detected conditions might obliviate the need for more complex interventions that require hospital admission. This does not, however, mean that all cancers and therefore all admissions for cancer are avoidable. Regarding thromboembolic venous disease, experts identified the early diagnosis and treatment as capable of avoiding hospitalizations. Finally, voluntary termination of pregnancy was considered avoidable if effective and timely family planning is accessible. All of these conditions verified the relevance for Public Health criterion proposed by Solberg and Weissman (hospitalization rate higher than 1/10.000 hab) being colorectal cancer, in fact, the fifth highest rate of ACSC hospitalization in Portugal in 2017. Although these criteria have been widely accepted, we do not agree that Public Health relevance should be strictly reduced to a hospitalization rate. For this reason, we propose two lists of ACSC, the core list including only the conditions that verify the hospitalizations rate criterion, and the extend list where all conditions considered ACSC by experts are included.

It is also noteworthy that other four conditions strongly related to behavioural and lifestyle decisions were newly proposed and almost reached consensus, namely alcoholic liver disease, hepatitis C, HIV infection and lung cancer. The health promotion capacity of primary care was identified as the technology that might prevent the onset of these diseases and therefore the need for hospitalization. It is also relevant to discuss that the recent pharmacological innovation for the treatment of HIV and hepatitis C viruses infection might render the need for hospitalization growingly residual.

Another important discussion topic is the consensus in not considering appendicitis with complication an ACSC and the lack of consensus in further nine previously considered conditions. This fact elicits the discussion on the context specificities to which is important to adapt the ACSC lists. This may also reflect the limitation of using experts' opinion to define ACSCs. In summary, the influx and efflux of conditions considered ACSC reflects the importance of regularly updating the lists. Nearly all the previous lists used in the comparison in Table [6](#Tab6){ref-type="table"} were developed more than 10 years ago. The constant development of knowledge, technology and healthcare design demands that the ACSC lists are updated more regularly.

Among the lists compared, the oldest one was proposed by Billings in 1993 \[[@CR1]\]. Out of the 16 conditions proposed by Billings, only 7 are included in the list developed for Portugal, reflecting the need of updating lists. The lists proposed by the AHRQ and CIHI are the ones with less conditions included, while the expanded list obtained for Portugal is composed of 40 conditions that include acute, chronic and vaccine-preventable diseases.

The rates of hospitalization in this paper are in line with previous studies regarding the most frequent ACSCs in Portugal being pneumonia, COPD, cardiovascular diseases, urinary tract infection and diabetes \[[@CR35], [@CR50]\]. These conditions are included in most of the previous lists presented in Table [6](#Tab6){ref-type="table"}.

Using the developed list, we identified that 15.7% of all hospitalizations were for ACSC. This is higher than what was found in previous studies, due to the inclusion of more conditions. Previous studies identified 4.4% \[[@CR36]\], 9.9% \[[@CR31]\] and 12.3% \[[@CR35]\] between 2012 and 2015. These studies used different lists, therefore the differences between results.

To estimate the ACSC hospitalizations' cost we used the best available proxy, as no billing system exists in Portugal, the "price" per hospitalization defined yearly by ACSS taking into consideration the diagnostic related groups methodology (all patients refined diagnosis related groups version 31.0) for the year 2017. Although this proxy might not represent the actual direct cost of ACSC it has been regularly used \[[@CR38], [@CR46]--[@CR48]\]. The estimated 352 million euros represents 2% of the overall Portuguese healthcare expenditure \[[@CR51]\]. According to the same source, the expenditure with public ambulatory care providers (excluding medication and diagnostic procedures) is 7.6%. This means that ACSC hospitalizations could cost yearly around 25% of what is spent with public ambulatory care providers. In another perspective, using the Gouveia et al. \[[@CR52]\] estimation for the price per consultation in the Portuguese Primary Health Care (74.90€/per consultation including medication and diagnostic procedures), the estimated cost of ACSC hospitalization would translate into more than 4,6 million consultations in PHC, around 15% of all consultations that occurred in 2017 \[[@CR53]\]. It is noteworthy that this exercise of cost-opportunity cannot be entirely fulfilled given that not all ACSC hospitalizations can be avoided.

The development of a validated list for the Portuguese context is important, as the use of a common methodology can standardize results, enhancing comparability within the country. The use of the country-specific list can also better reflect the health system organization and population characteristics of Portugal, therefore with a higher specificity to the Portuguese context. It does however hinder international comparability. Having validated an ACSC list for the Portuguese setting it is expected that henceforward official authorities and academic research use this list when measuring ACSC hospitalizations.

Finally, it is important to address some limitations inherent not only to this paper, but also to the concept and operationalization of ACSC as an indicator of access and quality of care.

The use of experts' opinion in the definition of ACSCs is subject to several biases, as well as the process of translating conditions into diagnosis codes. Furthermore, the use of administrative databases intended for financial purposes and subject to coding quality variations also recommends precaution in the interpretation of the results herein described. Such limitation is inherent to studies using these databases, as recognized by previous studies \[[@CR38], [@CR54], [@CR55]\]. However, these variations should not be relevant enough to compromise the overall picture, but should be taken into account when trying to zoom in to lower levels of aggregation. For example, while at the national and regional level this indicator is useful to identify Public Health priorities it might not be adequate at the local and individual level to evaluate specific providers' access and quality once the aforementioned biases may cause an important lack of specificity. It is commonly discussed in ACSC studies that this indicator of quality of care does not apply to the individual experience of the patient and the medical practice \[[@CR2], [@CR56], [@CR57]\].

The regional and local use should also take into account several determinants of ACSC hospitalizations, such as socioeconomic status, hospital distance and rurality \[[@CR58]--[@CR61]\], disease and multimorbidity prevalence \[[@CR9]\], in order to achieve a necessary risk adjustment of results.

Conclusion {#Sec5}
==========

We have developed a list of ACSCs for Portugal. This list includes conditions not identified in previous methodologies and excludes others previously identified thus increasing the specificity to the Portuguese context. Using this list to identify ACSC hospitalizations in Portugal, we have found a higher number of hospitalizations than what was estimated by previous studies. It is expected that this list could be used henceforward by epidemiologic studies, health services research and for healthcare management purposes. The identification of four new conditions contributes to the update of ACSC definition, highlighting that ACSC lists need to be frequently revisited and updated to keep up with technological and knowledge advances. Further research is necessary to increase the specificity of ACSC as an indicator of healthcare quality in smaller scales of analysis, such as individual or grouped providers. To increase this specificity, it will be necessary to determine how specific patient and context variables interact with each other in the pathway resulting in a ACSC hospitalization.

ACSC

:   Ambulatory Care Sensitive Conditions

ACSS

:   Administração Central do Sistema de Saúde

APMGF

:   Portuguese Association of General and Family Medicine

COPD

:   congestive obstructive pulmonary disease

CIHI

:   Canadian Institute for Health Information

GP

:   General practitioners

HBV

:   Hepatitis B virus

HIV

:   Human immunodeficiency virus

ICD10

:   International Classification of Diseases 10th Version

IM

:   Internal Medicine physicians

JS

:   João Sarmento

SPMI

:   Portuguese Society of Internal Medicine

RS

:   Rui Santana
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